Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics

被引:1
|
作者
Yook, Hwa Jung [1 ]
Lee, Ji Hyun [1 ]
机构
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, 222 Banpo Daero, Seoul 06591, South Korea
关键词
prurigo nodularis; chronic prurigo; treatment; NERVE-FIBER DENSITY; QUALITY-OF-LIFE; ATOPIC-DERMATITIS; DOUBLE-BLIND; COMBINATION THERAPY; MAST-CELLS; SCRATCHING BEHAVIOR; CONTROLLED-TRIAL; T-CELLS; RECEPTOR;
D O I
10.3390/ijms25105164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic pruritus that lasts for over 6 weeks can present in various forms, like papules, nodules, and plaque types, with prurigo nodularis (PN) being the most prevalent. The pathogenesis of PN involves the dysregulation of immune cell-neural circuits and is associated with peripheral neuropathies, possibly due to chronic scratching. PN is a persistent and challenging condition, involving complex interactions among the skin, immune system, and nervous system. Lesional skin in PN exhibits the infiltration of diverse immune cells like T cells, eosinophils, macrophages, and mast cells, leading to the release of inflammatory cytokines and itch-inducing substances. Activated sensory nerve fibers aggravate pruritus by releasing neurotransmitters, perpetuating a vicious cycle of itching and scratching. Traditional treatments often fail, but recent advancements in understanding the inflammatory and itch transmission mechanisms of PN have paved the way for innovative therapeutic approaches, which are explored in this review.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] MERKEL CELLS AND PRURIGO NODULARIS
    NAHASS, GT
    PENNEYS, NS
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 547 - 547
  • [42] THALIDOMIDE TREATMENT OF PRURIGO NODULARIS
    WINKELMANN, RK
    CONNOLLY, SM
    DOYLE, JA
    PADILHAGONCALVES, A
    ACTA DERMATO-VENEREOLOGICA, 1984, 64 (05) : 412 - 417
  • [43] PRURIGO-NODULARIS-HYDE
    MERK, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (16) : 640 - 640
  • [44] Prurigo nodularis and Hashimoto thyroiditis
    Rishi, Rahul
    Ringwala, Sudip
    Tracy, James
    Fatteh, Shahnaz
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (06) : 673 - +
  • [45] Immunotargets and Therapy for Prurigo Nodularis
    Labib, Angelina
    Ju, Teresa
    Vander Does, Ashley
    Yosipovitch, Gil
    IMMUNOTARGETS AND THERAPY, 2022, 11 : 11 - 21
  • [46] PRURIGO NODULARIS AND GLUTEN ENTEROPATHY
    MCKENZIE, AW
    STUBBING, DG
    ELVY, BL
    BRITISH JOURNAL OF DERMATOLOGY, 1976, 95 (01) : 89 - 92
  • [47] Treatment of prurigo nodularis with lenalidomide
    Ossorio-Garcia, Lidia
    Jimenez-Gallo, David
    Rodriguez-Mateos, Maria Eugenia
    Arjona-Aguilera, Cintia
    Linares-Barrios, Mario
    DERMATOLOGIC THERAPY, 2017, 30 (02)
  • [48] Prurigo nodularis of Hyde: an update
    Accioly, JW
    Nogueira, A
    Ramos-e-Silva, M
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2000, 14 (02) : 75 - 82
  • [49] Prurigo Nodularis and Dialyzer Membrane
    Goeksel, Tugce
    Xie, Wenhao
    Ritzerfeld, Maria
    Heidenreich, Stefan
    Mann, Helmut
    BLOOD PURIFICATION, 2013, 35 : 26 - 27
  • [50] A Fleshy Mystery: Prurigo Nodularis
    Bona, Jianna
    Pippin, Micah
    Atkins, Logan
    Al-Quraishi, Majeed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)